BB20023: Cancer biology
[Page last updated: 02 August 2022]
Academic Year: | 2022/23 |
Owning Department/School: | Department of Biology & Biochemistry |
Credits: | 6 [equivalent to 12 CATS credits] |
Notional Study Hours: | 120 |
Level: | Intermediate (FHEQ level 5) |
Period: |
|
Assessment Summary: | EX 60%, MC 20%, PR 20% |
Assessment Detail: |
|
Supplementary Assessment: |
|
Requisites: | |
Learning Outcomes: | After taking this unit, you will be able to:
* Demonstrate broad knowledge gained from current literature to compare the molecular, genetic and micro-environmental differences between cancer and normal tissues. * Interpret and analyse data from cutting-edge research publications in cancer genetics and therapy. * Acquire practical knowledge of drug discovery using cancer cells in culture. |
Aims: | To provide insights into the molecular and cellular processes underlying cancer and the rationale behind cancer therapy. |
Skills: | Learning and studying T/F/A, Written communication T/F/A, Laboratory skills T/F, Information technology T/F, Information handling & retrieval T/F/A, Working independently T/F. |
Content: | Molecular hallmarks of cancer. The role of oncogenes, tumour suppressor genes, the non-coding genome, the immune system, apoptosis, angiogenesis, metastasis among others, and link these to cancer therapeutic targets. |
Programme availability: |
BB20023 is Compulsory on the following programmes:Department of Biology & Biochemistry
BB20023 is Optional on the following programmes:Department of Biology & Biochemistry
|
Notes:
|